Sarcoma  >>  ontuxizumab (MORAb-004)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ontuxizumab (MORAb-004) / Eisai
NCT01574716 / 2012-001399-12: Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation

Completed
2
209
Europe, US, RoW
MORAb-004, Gemcitabine, Docetaxel, Placebo
Morphotek
Metastatic Soft Tissue Sarcoma
08/15
08/16

Download Options